Abstract
Objective
To evaluate the clinical effectiveness of contact transscleral cyclophotocoagulation (CTCP) with diode laser.
Design and Patients
Forty-eight seeing eyes and 20 blind and painful eyes of 68 patients suffering from refractory glaucoma were treated using a diode laser (EOS3000, Laser Science) coupled with a 400-μm optic fiber ending in a 3-mm focusing tip. Sixteen to twenty 3.9-J (2.6 W x 1.5 to 2.5 s) laser spots were placed over 360°, 1.5 mm from the corneolimbal junction.
Results
In the seeing-eye group, the follow-up was 20.7 ± 8.14 months, pre- and posttreat-ment lOPs were 37.1 ± 11.27 and 19.5 ± 8.73 mmHg respectively (p < 0.0001), and success (IOP > 2 and < 21 mmHg) was 70.8%. No significant visual acuity change was found in the successful eyes, whereas a significant visual acuity reduction was found in the unsuccessful cases (p=0.03). In the blind-eye group, the follow-up was 20.5 ± 8.54 months, pre- and post-treatment lOPs were 50.7 ± 15.05 and 20.6 ± 13.99 mmHg respectively (p < 0.0001), and success (remission of pain) was 100%. As for complications, one seeing eye developed a spontaneously-resolved vitreous hemorrhage and one seeing and one blind eye became hypotonic, though no phthysis was observed.
No conjunctival or lens damage was detected, and no scleral thinning was revealed by ultrasound biomicroscopy. No case of sympathetic ophthalmia was found.
Conclusions
Diode laser can be successfully employed for CTCP in refractory glaucoma.
Get full access to this article
View all access options for this article.